يعرض 1 - 10 نتائج من 41 نتيجة بحث عن '"Girnius, Saulius K."', وقت الاستعلام: 1.29s تنقيح النتائج
  1. 1
    دورية أكاديمية
    PB2089: IN-CLASS TRANSITION FROM PARENTERAL BORTEZOMIB TO ORAL IXAZOMIB IN NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM) ACCORDING TO AGE AND FRAILTY STATUS: UPDATED SUBGROUP ANALYSIS OF US MM-6

    المؤلفون: Girnius, Saulius K., Richter, Joshua, Lyons, Roger M., Bogard, Kimberly, Manda, Sudhir, Birhiray, Ruemu E., Yimer, Habte A., Tran, Kim, Kambhampati, Suman, Arora, Jyoti, Noga, Stephen, Rifkin, Robert

    المصدر: HemaSphere ; volume 7, issue S3, page e149880d ; ISSN 2572-9241

    الإتاحة: https://doi.org/10.1097/01.hs9.0000975148.14988.0dTest

    View record in BASE

    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    In-class transition (iCT) of proteasome inhibitor-based therapy: a community approach to multiple myeloma management

    المؤلفون: Rifkin, Robert M., Girnius, Saulius K., Noga, Stephen J., Birhiray, Ruemu E., Kambhampati, Suman, Manda, Sudhir, Lyons, Roger M., Yimer, Habte A., Cherepanov, Dasha, Lloyd, Eric, Whidden, Presley, Richter, Joshua

    المساهمون: Takeda Development Center Americas, Inc.

    المصدر: Blood Cancer Journal ; volume 13, issue 1 ; ISSN 2044-5385

    مصطلحات موضوعية: Oncology, Hematology

    الإتاحة: https://doi.org/10.1038/s41408-023-00912-9Test
    https://www.nature.com/articles/s41408-023-00912-9.pdfTest
    https://www.nature.com/articles/s41408-023-00912-9Test

    View record in BASE

    أضف إلى المفضلة
  3. 3
    دورية أكاديمية
    POSTER: MM-465 In-Class Transition (iCT) from Parenteral Bortezomib-Based Induction to All-Oral Ixazomib-Lenalidomide-Dexamethasone in Transplant-Ineligible Patients With Newly Diagnosed Multiple Myeloma (NDMM): Updated Subgroup Analysis from the Community-Based US MM-6 Study

    المؤلفون: Girnius, Saulius K., Richter, Joshua, Lyons, Roger, Bogard, Kimberly, Manda, Sudhir, Birhiray, Ruemu E., Yimer, Habte A., Tran, Kim, Kambhampati, Suman, Arora, Jyoti, Noga, Stephen J., Rifkin, Robert M.

    المصدر: Clinical Lymphoma Myeloma and Leukemia ; volume 23, page S221 ; ISSN 2152-2650

    مصطلحات موضوعية: Cancer Research, Oncology, Hematology

    الإتاحة: https://doi.org/10.1016/s2152-2650Test(23)00835-2
    https://api.elsevier.com/content/article/PII:S2152265023008352?httpAccept=text/xmlTest
    https://api.elsevier.com/content/article/PII:S2152265023008352?httpAccept=text/plainTest

    View record in BASE

    أضف إلى المفضلة
  4. 4
    دورية أكاديمية
    MM-465 In-Class Transition (iCT) from Parenteral Bortezomib-Based Induction to All-Oral Ixazomib-Lenalidomide-Dexamethasone in Transplant-Ineligible Patients With Newly Diagnosed Multiple Myeloma (NDMM): Updated Subgroup Analysis from the Community-Based US MM-6 Study

    المؤلفون: Girnius, Saulius K., Richter, Joshua, Lyons, Roger, Bogard, Kimberly, Manda, Sudhir, Birhiray, Ruemu E., Yimer, Habte A., Tran, Kim, Kambhampati, Suman, Arora, Jyoti, Noga, Stephen J., Rifkin, Robert M.

    المصدر: Clinical Lymphoma Myeloma and Leukemia ; volume 23, page S501 ; ISSN 2152-2650

    مصطلحات موضوعية: Cancer Research, Oncology, Hematology

    الإتاحة: https://doi.org/10.1016/s2152-2650Test(23)01456-8
    https://api.elsevier.com/content/article/PII:S2152265023014568?httpAccept=text/xmlTest
    https://api.elsevier.com/content/article/PII:S2152265023014568?httpAccept=text/plainTest

    View record in BASE

    أضف إلى المفضلة
  5. 5
    دورية أكاديمية
    Hispanics have the lowest stem cell transplant utilization rate for autologous hematopoietic cell transplantation for multiple myeloma in the United States: A CIBMTR report

    المؤلفون: Schriber, Jeffrey R., Hari, Parameswaran N., Ahn, Kwang Woo, Fei, Mingwei, Costa, Luciano J., Kharfan‐Dabaja, Mohamad A., Angel‐Diaz, Miguel, Gale, Robert P., Ganguly, Siddharatha, Girnius, Saulius K., Hashmi, Shahrukh, Pawarode, Attaphol, Vesole, David H., Wiernik, Peter H., Wirk, Baldeep M., Marks, David I., Nishihori, Taiga, Olsson, Richard F., Usmani, Saad Z., Mark, Tomer M., Nieto, Yago L., D'Souza, Anita

    المساهمون: Medical College of Wisconsin, National Center for Advancing Translational Sciences, National Institutes of Health, National Cancer Institute, National Heart, Lung, and Blood Institute, National Institute of Allergy and Infectious Diseases, Health Resources and Services Administration, Office of Naval Research

    المصدر: Cancer ; volume 123, issue 16, page 3141-3149 ; ISSN 0008-543X 1097-0142

    الإتاحة: https://doi.org/10.1002/cncr.30747Test

    View record in BASE

    أضف إلى المفضلة
  6. 6
    دورية أكاديمية
    MM-253 Efficacy, Safety, and Quality of Life (QoL) in Patients With Newly Diagnosed Multiple Myeloma (NDMM) After In-Class Transition (iCT) From Parenteral Bortezomib-Based Induction Therapy to All-Oral Ixazomib-Lenalidomide-Dexamethasone (IRd): Data From the Phase 4, Community-Based US MM-6 Study (Fully Accrued Cohort)

    المؤلفون: Manda, Sudhir, Yimer, Habte A., Birhiray, Ruemu E., Boccia, Ralph, Kambhampati, Suman, Richter, Joshua, Aiello, Jack, Girnius, Saulius K., Cherepanov, Dasha, Tran, Kim, Whidden, Presley, Noga, Stephen J., Rifkin, Robert M.

    المصدر: Clinical Lymphoma Myeloma and Leukemia ; volume 22, page S416-S417 ; ISSN 2152-2650

    مصطلحات موضوعية: Cancer Research, Oncology, Hematology

    الإتاحة: https://doi.org/10.1016/s2152-2650Test(22)01610-x
    https://api.elsevier.com/content/article/PII:S215226502201610X?httpAccept=text/xmlTest
    https://api.elsevier.com/content/article/PII:S215226502201610X?httpAccept=text/plainTest

    View record in BASE

    أضف إلى المفضلة
  7. 7
    دورية أكاديمية
    Poster: MM-253 Efficacy, Safety, and Quality of Life (QoL) in Patients With Newly Diagnosed Multiple Myeloma (NDMM) After In-Class Transition (iCT) From Parenteral Bortezomib-Based Induction Therapy to ALL-Oral Ixazomib-Lenalidomide-Dexamethasone (IRd): Data From the Phase 4, Community-Based US Poster: MM-6 Study (Fully Accrued Cohort)

    المؤلفون: Manda, Sudhir, Yimer, Habte A., Birhiray, Ruemu E., Boccia, Ralph, Kambhampati, Suman, Richter, Joshua, Aiello, Jack, Girnius, Saulius K., Cherepanov, Dasha, Tran, Kim, Whidden, Presley, Noga, Stephen J., Rifkin, Robert M.

    المصدر: Clinical Lymphoma Myeloma and Leukemia ; volume 22, page S179 ; ISSN 2152-2650

    مصطلحات موضوعية: Cancer Research, Oncology, Hematology

    الإتاحة: https://doi.org/10.1016/s2152-2650Test(22)01101-6
    https://api.elsevier.com/content/article/PII:S2152265022011016?httpAccept=text/xmlTest
    https://api.elsevier.com/content/article/PII:S2152265022011016?httpAccept=text/plainTest

    View record in BASE

    أضف إلى المفضلة
  8. 8
    دورية أكاديمية
    A Phase II trial of weekly bortezomib and dexamethasone in veterans with newly diagnosed multiple myeloma not eligible for or who deferred autologous stem cell transplantation

    المؤلفون: Girnius, Saulius K., Lee, Saem, Kambhampati, Suman, Rose, Michal G., Mohiuddin, Abid, Houranieh, Antoun, Zimelman, Abraham, Grady, Terrence, Mehta, Paulette, Behler, Caroline, Hayes, Teresa G., Efebera, Yvonne A., Prabhala, Rao H., Han, Andrew, Yellapragada, Sarvari V., Klein, Catherine E., Roodman, Garson D., Lichtenstein, Alan, Munshi, Nikhil C.

    المصدر: British Journal of Haematology ; volume 169, issue 1, page 36-43 ; ISSN 0007-1048 1365-2141

    الإتاحة: https://doi.org/10.1111/bjh.13243Test

    View record in BASE

    أضف إلى المفضلة
  9. 9
    دورية أكاديمية
    MM-202: Long-Term Proteasome Inhibition in Multiple Myeloma (MM) Following an in-Class Transition (iCT) from Bortezomib-Based Induction to All-Oral Ixazomib-Lenalidomide-Dexamethasone (IRd) in the United States (US) MM-6 Community-Based Study: Subgroup Analyses of Real-World Data in Patients Aged

    المؤلفون: Birhiray, Ruemu E., Manda, Sudhir, Girnius, Saulius K., Lyons, Roger M., Boccia, Ralph V., Jhangiani, Haresh S., Kambhampati, Suman, Rifkin, Robert M., Bogard, Kimberly, Whidden, Presley, Cherepanov, Dasha, Noga, Stephen J., Yimer, Habte A.

    المصدر: Clinical Lymphoma Myeloma and Leukemia ; volume 20, page S299 ; ISSN 2152-2650

    مصطلحات موضوعية: Cancer Research, Oncology, Hematology

    الإتاحة: https://doi.org/10.1016/s2152-2650Test(20)30939-3
    https://api.elsevier.com/content/article/PII:S2152265020309393?httpAccept=text/xmlTest
    https://api.elsevier.com/content/article/PII:S2152265020309393?httpAccept=text/plainTest

    View record in BASE

    أضف إلى المفضلة
  10. 10
    دورية
    In-Class Transition ( iCT) from Parenteral Bortezomib (V) to Oral Ixazomib Therapy in Newly Diagnosed Multiple Myeloma (NDMM) Patients (Pts) in the Community-Based US MM-6 Study: Subanalysis of Randomized Controlled Trial (RCT)-Ineligible and RCT-Eligible Pts

    المؤلفون: Girnius, Saulius K., Richter, Joshua, Bogard, Kimberly, Yimer, Habte A., Manda, Sudhir, Lyons, Roger M., Noga, Stephen J., Rifkin, Robert M.

    المصدر: Blood; November 2023, Vol. 142 Issue: 1, Number 1 Supplement 1 p6677-6677, 1p


    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث